✦ LIBER ✦

LDL-apheresis in pediatric patients with severe hyperlipoproteinemia

✍ Scribed by C. Stefanutti; A. Vivenzio; C. Colombo; S. Di Giacomo; B. Mazzarella; A. Berni; A. Nigri; N. Koga

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 107 KB
Volume: 10
Category: Article
ISSN: 0733-2459
DOI: 10.1002/jca.2920100210

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term effects of LDL apheresis in pa

Long-term effects of LDL apheresis in patients with severe hypercholesterolemia

✍ Bruce S. Sachais; Julie Katz; Joyce Ross; Daniel J. Rader 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

Familial hypercholesterolemia (FH) is an inherited disorder of lipoprotein metabolism involving mutations in the LDL receptor (LDL-R). Patients with mutation in one (heterozygous) or both (homozygous) genes have markedly elevated LDL cholesterol and are at increased risk for coronary heart disease (

Apheresis in the pediatric patient

✍ Christina A. Kasprisin; Duke O. Kasprisin 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 1 views

As therapeutic apheresis becomes more and more popular, its use in children has remained limited. in most cases, the reports that do exist are either brief abstracts or a notation in a larger group of adult patients.

Pancytopenia with severe thrombocytopeni

Pancytopenia with severe thrombocytopenia in a patient treated with twice-weekly LDL-apheresis by polyacrylate adsorption from whole blood

✍ Rainer Nowack; Günther Wiedemann 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

## Abstract Pancytopenia with severe thrombocytopenia occurred in a patient treated with low‐density lipoprotein (LDL)‐apheresis by polyacrylate adsorption from whole blood, after treatment frequency had been increased from once to twice a week. Cell counts recovered with discontinuation of LDL‐aph

Use of Losartan in FH patients during tr

Use of Losartan in FH patients during treatment with DSC-LDL apheresis

✍ S. Pintus; P. Pintus; P. Maxia; S. Anedda 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 6 KB 👁 2 views

Angiotensin-converting-enzyme (ACE) inhibitors reduce morbidity and mortality in patients with chronic heart failure and systolic left-ventricular dysfunction, as well as in patients who have had a myocardial infarction . These drugs, in familial hypercholesterolemic (FH) patients treated with low-d

VEGF levels in patients with peripheral

VEGF levels in patients with peripheral arterial occlusive disease receiving LDL-apheresis

✍ Simone Ferrero 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 1 views

LDL-apheresis up-regulates VEGF and IGF-

LDL-apheresis up-regulates VEGF and IGF-I in patients with ischemic limb

✍ Shuzo Kobayashi; Hidekazu Moriya; Kousuke Negishi; Kyouko Maesato; Takayasu Ohta 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract Although it is known that LDL‐apheresis improves ischemic limb seen in patients with peripheral arterial occlusive disease (PAOD), the underlying mechanism(s) still remains unknown. We studied whether vascular endothelial growth factor (VEGF) and/or insulin‐like growth factor‐I (IGF‐I)